FIGURE

Figure 2

ID

ZDB-FIG-211029-128

Publication

Robinson et al., 2021 - A Novel Calpain Inhibitor Compound Has Protective Effects on a Zebrafish Model of Spinocerebellar Ataxia Type 3

Other Figures

All Figure Page

Back to All Figure Page

Figure 2

Treatment with BLD-2736 from 1 to 6 days post-fertilization reduces the presence of ataxin-3 protein species. (A) Representative scatterplots showing flow cytometric detection of detergent-insoluble EGFP-fused ataxin-3 particles following calpain inhibitor treatments. (B) The number of detergent-insoluble EGFP particles relative to nuclei was decreased following treatment with calpain inhibitors. (C) Representative western blot showing the presence of full length and cleaved ataxin-3 protein species. (D) Calpain inhibitor treatments were found to decrease the presence of full length ataxin-3 species in a dose-dependent manner. (E) Calpain inhibitor treatments also produced a decrease in the presence of cleaved ataxin-3 species, as detected by Western blotting. All data are presented as mean ± SEM. Each data point represents a single experimental replicate, where samples were pooled from n = 12–20 zebrafish larvae. * represents p < 0.05, ** represents p < 0.01, *** represents p < 0.001, **** represents p < 0.0001.

Expression Data

Gene:	EGFP
Fish:	mq15Tg; mq17Tg
Conditions:	chemical treatment by environment: calpain inhibitor chemical treatment by environment: Calpeptin
Anatomical Term:	whole organism
Stage:	Day 6

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	mq15Tg; mq17Tg
Conditions:	chemical treatment by environment: calpain inhibitor chemical treatment by environment: Calpeptin
Observed In:	whole organism
Stage:	Day 6

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells